Are we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?

Vista sencilla de Ć­tem
dc.contributor.authorRodriguez-Martinez, Carlos E.
dc.contributor.authorSossa-BriceƱo, Monica P.
dc.date.accessioned2021-06-25T22:37:26Z
dc.date.available2021-06-25T22:37:26Z
dc.date.issued2021-06-09
dc.description.abstractenglishObjective To perform a narrative review to describe and discuss potential methods and strategies for effectively assessing and dealing with poor adherence and/or misuse of inhalers in difficult-to-treat pediatric asthmatic patients. Data sources Articles available in electronic databases, published from inception to April 2021. Study selections Relevant articles in the literature that discuss and analyze potential methods and strategies for effectively assessing and dealing with poor adherence and/or misuse of inhalers in difficult-to-treat pediatric asthmatic patients. Results Validated self-reported questionnaires, weighing inhaler canisters, and pharmacy records might be the most suitable methods for assessing adherence to inhaled controller therapy in clinical practice. Additionally, validated instruments could be used as an objective measurement of the adequacy of inhaler technique. Finally, empathy and a true and strong physician-parent/patient partnership have a more powerful influence on adherence than almost any other factor, and they are probably the most cost-effective methods not only for detecting poor adherence to controller therapy but also for dealing with and improving it. Conclusions Failure to detect or effectively handle nonadherence and/or inhaler misuse in a patient with uncontrolled asthma can mislead clinicians into thinking that the patient is nonresponsive to the original less-intensive therapy, resulting in unneeded dosage increases and/or escalation of controller therapy to more costly medications, in some cases reaching the level of biologic therapy.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1080/02770903.2021.1936016
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1532-4303
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/5913
dc.language.isoeng
dc.publisherTaylor & Francisspa
dc.publisher.journalJournal of Asthmaspa
dc.relation.ispartofseriesJournal of Asthma, 1532-4303, 2021spa
dc.relation.urihttps://www.tandfonline.com/doi/abs/10.1080/02770903.2021.1936016?journalCode=ijas20
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.localAcceso abiertospa
dc.subject.keywordsAsthmaspa
dc.subject.keywordsCost-effectivenessspa
dc.subject.keywordsEscalation of therapyspa
dc.subject.keywordsTreatment adherence and compliancespa
dc.titleAre we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?spa
dc.title.translatedAre we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?spa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtĆ­culo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Rodriguez_Martinez_Carlos E._2021.pdf
TamaƱo:
1.19 MB
Formato:
Adobe Portable Document Format
DescripciĆ³n:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
TamaƱo:
1.71 KB
Formato:
Item-specific license agreed upon to submission
DescripciĆ³n:
Descargar

Colecciones

ArtĆ­culos